PolyPid (FRA:2PV) Shareholder Yield % : 6.08% (As of Mar. 2026)


FRA:2PV PolyPid Ltd FRA:2PV
14 GF Score
Price €3.99
! 1 Warning Sign
View Full Analysis

What is PolyPid Shareholder Yield %?

PolyPid FRA:2PV -9.43% 14 Shareholder Yield % is 6.08% as of Mar. 2026. GuruFocus rates FRA:2PV with a GF Score™ of 14/100. The stock has 1 warning sign investors should review. Among 1,301 Biotechnology companies, PolyPid ranks better than 91.24% on this metric.

Shareholder Yield % is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. It is a measure of shareholder return. As of today, PolyPid's Shareholder Yield % was 6.08%.


PolyPid  (FRA:2PV) Shareholder Yield % Explanation

Shareholder Yield % is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. The term was coined by William W. Priest of Epoch Investment Partners in a paper in 2005 entitled The Case for Shareholder Yield as a Dominant Driver of Future Equity Returns. William Priest indicated that "shareholder yield is a term that we came up with to reflect the various ways dividends can be paid to owners of a business in a publicly-traded company."

Shareholder Yield % is calculated by three components: Dividend Yield %, Buyback Yield %, and Net Debt Paydown Yield %.

Dividend Yield % shows how much a company pays out in dividends each year relative to its stock price, which is most obvious form of shareholder return.

Buyback Yield % is the net repurchase of shares outstanding over the market capital of the company. Shares repurchases also increase shareholder value by returning the money back to shareholders.

Net Debt Paydown Yield % is the change in average of four quarters of company's total debt over a company's market cap. Assuming the total value of a company remains that same, shareholder value is increased as debt is reduced.


PolyPid Shareholder Yield % Related Terms


PolyPid Shareholder Yield % Historical Data

* Premium members only.

The historical data trend for PolyPid's Shareholder Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PolyPid Shareholder Yield % Chart

PolyPid Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Shareholder Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 -36.17 -213.76 -110.46 -35.75

PolyPid Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Shareholder Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.98 4.04 5.76 -35.75 6.35

FRA:2PV vs LONA, ANIX, SGMO: Shareholder Yield % Comparison

For the Biotechnology subindustry, PolyPid's Shareholder Yield %, along with its competitors' market caps and Shareholder Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PolyPid Shareholder Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PolyPid's Shareholder Yield % distribution charts can be found below:

* The bar in red indicates where PolyPid's Shareholder Yield % falls into.


FRA:2PV
14GF Score
PolyPid Ltd FRA:2PV
Shareholder Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PolyPid Shareholder Yield % Calculation

PolyPid's Shareholder Yield % for the quarter that ended in Mar. 2026 is calculated as:

Shareholder Yield %=Dividend Yield %+Buyback Yield %+Net Debt Paydown Yield %
=0.00 %+0.00 %+0 %
=0 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* All the data are calculated by TTM values. Note that if a companies is traded in several exchanges, then we calculate the company level data for Shareholder Yield % using the primary share class stock data. The calculation result in definition page is for demonstration purpose only, and it's showing the share class level data. Therefore, the numbers in the calculation may differ from elsewhere if the stock is not a primary share.

Frequently Asked Questions Learn more about Shareholder Yield % →
What does a Shareholder Yield % of 6.08% mean?
PolyPid (FRA:2PV) has a Shareholder Yield % of 6.08% as of Mar. 2026. Shareholder Yield is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. View historical data on PolyPid and its competitors. According to the industry distribution chart, PolyPid ranks #114 out of 1301 companies in the Biotechnology industry, placing it in the top 8.8%.
Is PolyPid's Shareholder Yield % too high?
PolyPid's current Shareholder Yield % is 6.08%. Based on the distribution chart, PolyPid ranks #114 out of 1301 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, PolyPid has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does PolyPid's Shareholder Yield % compare to LONA and ANIX?
According to the Biotechnology industry distribution chart, PolyPid ranks #114 out of 1301 companies for Shareholder Yield %. This places PolyPid in the top 9% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shareholder Yield % for a Biotechnology company?
A good Shareholder Yield % depends on the Biotechnology industry context. However, Shareholder Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shareholder Yield % mean?
A high Shareholder Yield % can signal that a stock is expensive relative to its fundamentals. Shareholder Yield is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. View historical data on PolyPid and its competitors. PolyPid's current Shareholder Yield % is 6.08%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PolyPid stock overvalued right now?
PolyPid (FRA:2PV) has a current Shareholder Yield % of 6.08%. The current Shareholder Yield % is 6.08%. PolyPid's overall GF Score™ is 14/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shareholder Yield % calculated?
Shareholder Yield % is calculated from a company's financial statements. For PolyPid (FRA:2PV), the current Shareholder Yield % is 6.08% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PolyPid Business Description

Other Exchanges PYPD:USA
Address 18 Hasivim Street, Petach Tikva, ISR, 495376
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. The company's product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.
14GF Score

Get the complete analysis for FRA:2PV

Shareholder Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€3.99
Price